General description
DHEA is an endogenous steroid that has been implicated in a broad range of biological effects in humans and other mammals. Besides testing under the World Anti-Doping Code of the World Anti-Doping Agency (WADA), DHEA levels are also measured for newborn screening of congenital adrenal hyperplasia (CAH) and for determination of hyperandrogenic conditions such as polycystic ovarian syndrome and adrenal tumors. This calibration material is suitable for GC/MS and LC/MS applications from clinical and diagnostic testing and endocrinology to sports testing.
Legal Information
CERILLIANT is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Cerilliant Corporation
Molecular Weight: 288.42. Empirical Formula: C19H28O2. grade: certified reference material. Quality Level: 300. form: liquid. feature: Snap-N-Spike®. /Snap-N-Shoot®. . packaging: ampule of 1 . mL. manufacturer/tradename: Cerilliant®. . concentration: 1.0 . mg/mL in methanol. technique(s): gas chromatography (GC): suitable, liquid chromatography (LC): suitable. application(s): clinical testing. format: single component solution. storage temp.: −. 20°C. SMILES string: C[C@]12CC[C@H]3[C@@H](CC: C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2: O. InChI: 1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-16,20H,4-11H2,1-2H3/t13-,14-,15-,16-,18-,19-/m0/s1. InChI key: FMGSKLZLMKYGDP-USOAJAOKSA-N. Pictograms: GHS02,GHS06,GHS08. Signal Word: Danger. Hazard Statements: H225 - H301 + H311 + H331 - H370. Precautionary Statements: P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311. Hazard Classifications: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1. Storage Class Code: 3 - Flammable liquids. WGK: WGK 2. Flash Point(F): 49.5 °F - closed cup. Flash Point(C): 9.7 °C - closed cup.- UPC:
- 51182012
- Condition:
- New
- HazmatClass:
- Yes
- MPN:
- D-063-1ML
- CAS:
- 53-43-0
akash.verma@cenmed.com
(732) 447-1115





